Home | Business News | Browse by Publication | P | Pharma Marketletter

Zeltia's first-half sales up 6.4%.

Publication: Pharma Marketletter
Publication Date: 02-AUG-04
Format: Online
Delivery: Immediate Online Access
Full Article Title: Zeltia's first-half sales up 6.4%.(financial results)(Brief Article)

Article Excerpt
Spain's Zeltia has recorded sales of 42.8 million euros ($52.0 million) for the first half of 2004, marking a 6.4% rise on those posted for the year-earlier period. The company's subsidiaries, Zelnova and Xylazel, generated 94.3% of total group revenues, the firm noted.

Net financial loss reached 371,000 euros...



More articles from Pharma Marketletter
Genetix' profits up 45% for 1st-half.(financial results of Genetix Gro..., August 02, 2004
UK NICE "conquering the world, but....".(National Institute for Clinic..., August 02, 2004
Chiron names Ursula Bartels VP and general counsel.(vice president)(Br..., August 02, 2004
Sequenom closes pharm unit; reports 2nd-qtr results.(Brief Article), August 02, 2004
Lonza signs niacin production deal with Innovite.(Brief Article), August 02, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.